2017年12月15日
 
                               Early Equity Plc
                          
                          (“Early Equity” 或 “公司”)
 
投资TruSpine Technologies Limited和Farina Investments(UK)Limited
 
Early Equity很高兴地宣布已经进行了以下投资:
 
TruSpine Technologies Limited
 
Early Equity通过认购方式向TruSpine Technologies Limited(“TruSpine”)
投资60,000英镑,新推出的资金估值为1,500万英镑。 TruSpine成立于2014年12月,
获得知识产权,随后开发了Faci-LOK和Cervi-FAS微创脊柱稳定装置,以及VOSC
导管动脉粥样硬化治疗产品'VOSC导管'。这种发展正在持续进行,TruSpine的目标
是FDA的第一个产品Faci-LOK的清理和商业化。 FDA将于2017年第四季度末提交。
预计将于2018年收到FDA批准后进行AIM IPO。截至2016年3月31日止年度,
TruSpine发生亏损45,325英镑。
 

Farina投资(英国)有限公司
 
Early Equity通过认购方式以4亿英镑的全新资金估值向Farina Investments
(UK)Limited(“Farina”)投资35,000英镑。 Farina是一家精品企业融资
和资产管理公司,专门从事危机后金融领域的利润机会。法里纳经过精心组织
和战略布局,充分利用这些机会,从而优化公司和投资者的资本增长,盈利
能力和回报。 Farina目前正在通过IPO或反向收购来探索各种英国上市机会。
截至2016年7月31日止年度,营业额为190万英镑,净利润为116,000英镑,
管理资产为180万英镑。 Farina未经金融行为监管局授权和监管。

 
执行董事Chua Siew Lian评论道:
 
“我们很高兴能够探索这些符合我们投资策略的机会,这些投资策略专注于
早期阶段的公司。在过去的几个月中,我们已经在马来西亚投入了大量资金,
这些投资显示了公司在行业和地域上的多样性。
 
公司不断寻求新的机会。
 
Early Equity Plc的董事负责本公告。
 
欲了解更多信息,请联系:
 
Greg Collier 
 
Tel: +44 7830 182501 
 
NEX CORPORATE ADVISER: 
 
Alexander David Securities Limited 
 
David Scott -Corporate Finance 
 
James Dewhurst - Institutional Sales 
 
Telephone: +44 (0) 20 7448 9820 
 
http://www.ad-securities.com 
 
49 Queen Victoria Street, London EC4N 4SA


备注:此中文版本为英文版本的译本。若中文译本与英文版本的原文内容有任何不一致之处,应以英文版本为准。

 
 
 15 December 2017 
 
                            Early Equity PLC 

                     ("Early Equity" or "the Company") 
 
Investment in TruSpine Technologies Limited and Farina Investments (UK) Limited 
 
Early Equity is pleased to announce it has made the following investments: 
 
TruSpine Technologies Limited 
 
Early Equity has invested, by way of subscription, GBP60,000 in TruSpine 
Technologies Limited ("TruSpine") on a pre-new money valuation of GBP15m. Founded 
in December 2014, TruSpine secured intellectual property and subsequently 
developed the Faci-LOK and Cervi-FAS minimally invasive spine stabilisation 
devices, and the VOSC Catheter atherosclerosis treatment product 'VOSC 
Catheter'. This development is on-going and TruSpine is targeting FDA clearance 
and commercialisation of its first product, the Faci-LOK. FDA submission is 
expected by the end of Q4 2017. An AIM IPO is planned to take place following 
FDA approval, which is expected to be received in 2018. In the year ended 31 
March 2016, TruSpine incurred a loss of GBP45,325. 
 
Farina Investments (UK) Limited 
 
Early Equity has invested, by way of subscription, GBP35,000 in Farina 
Investments (UK) Limited ("Farina") on a pre-new money valuation of GBP4m. Farina 
is a boutique corporate finance and asset management company which specialises 
in leveraging profit opportunity in the post-crisis financial landscape. Farina 
has been carefully structured and strategically placed to fully capitalise on 
these opportunities, thereby optimising capital growth, profitability and 
returns for both the company and investors. Farina is currently exploring 
various UK listing opportunities either via IPO or reverse takeover. In the 
year ended 31 July 2016, turnover was GBP1.9 million, net profit was GBP116,000 and 
assets under management were GBP1.8 million. Farina is not authorised and 
regulated by the Financial Conduct Authority. 
 
Chua Siew Lian, Executive Director commented: 
 
"We are very pleased to explore these opportunities that are in line with our 
investment strategy focused on early stage companies. Over the past months we 
have invested significantly in Malaysia and these investments demonstrate the 
diversity of the Company by sector and also geographically. 
 
The Company continues to seek new opportunities. 
 
The directors of Early Equity Plc accept responsibility for this announcement. 
 
For further information please contact: 
 
Greg Collier 
 
Tel: +44 7830 182501 
 
NEX CORPORATE ADVISER: 
 
Alexander David Securities Limited 
 
David Scott -Corporate Finance 
 
James Dewhurst - Institutional Sales 
 
Telephone: +44 (0) 20 7448 9820 
 
http://www.ad-securities.com 
 
49 Queen Victoria Street, London EC4N 4SA